Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228786 |
APO-ATOMOXETINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228792 |
APO-RIVAROXABAN | 15MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228801 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228804 |
APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228813 |
APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-05-30 | 225101 |
APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229161 |
APO-ATOMOXETINE | 25MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229164 |
APO-ATOMOXETINE | 40MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229167 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-30 | 219843 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-30 | 227082 |
APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Actual shortage | 2024-05-24 | 2024-05-30 | 228807 |
APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-30 | 227065 |
APO-AMIODARONE TABLETS | 200MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-30 | 228816 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-07-13 | 2024-05-31 | 198539 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-05-10 | 2024-05-31 | 227717 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224977 |
APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224996 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |